These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 29134378)

  • 41. Critical appraisal of the 'wait and see' approach in rectal cancer for clinical complete responders after chemoradiation.
    Glynne-Jones R; Hughes R
    Br J Surg; 2012 Jul; 99(7):897-909. PubMed ID: 22539154
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Delaying surgery after neoadjuvant chemoradiotherapy in rectal cancer has no influence in surgical approach or short-term clinical outcomes.
    Figueiredo N; Panteleimonitis S; Popeskou S; Cunha JF; Qureshi T; Beets GL; Heald RJ; Parvaiz A
    Eur J Surg Oncol; 2018 Apr; 44(4):484-489. PubMed ID: 29398323
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quality of Life in Rectal Cancer Patients After Chemoradiation: Watch-and-Wait Policy Versus Standard Resection - A Matched-Controlled Study.
    Hupkens BJP; Martens MH; Stoot JH; Berbee M; Melenhorst J; Beets-Tan RG; Beets GL; Breukink SO
    Dis Colon Rectum; 2017 Oct; 60(10):1032-1040. PubMed ID: 28891846
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal Cancer.
    Nahas SC; Rizkallah Nahas CS; Sparapan Marques CF; Ribeiro U; Cotti GC; Imperiale AR; Capareli FC; Chih Chen AT; Hoff PM; Cecconello I
    Dis Colon Rectum; 2016 Apr; 59(4):255-63. PubMed ID: 26953983
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outcomes after the watch-and-wait strategy and local excision treatment for rectal cancer: a meta-analysis.
    Li J; Ma Y; Wen L; Zhang G; Yao X
    Expert Rev Anticancer Ther; 2023 May; 23(5):555-564. PubMed ID: 36795784
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparing outcomes and cost in surgery versus watch & wait surveillance of patients with rectal cancer post neoadjuvant long course chemoradiotherapy.
    Crean R; Glyn T; McCombie A; Frizelle F
    ANZ J Surg; 2024 Jun; 94(6):1151-1160. PubMed ID: 38486505
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis.
    Chadi SA; Malcomson L; Ensor J; Riley RD; Vaccaro CA; Rossi GL; Daniels IR; Smart NJ; Osborne ME; Beets GL; Maas M; Bitterman DS; Du K; Gollins S; Sun Myint A; Smith FM; Saunders MP; Scott N; O'Dwyer ST; de Castro Araujo RO; Valadao M; Lopes A; Hsiao CW; Lai CL; Smith RK; Paulson EC; Appelt A; Jakobsen A; Wexner SD; Habr-Gama A; Sao Julião G; Perez R; Renehan AG
    Lancet Gastroenterol Hepatol; 2018 Dec; 3(12):825-836. PubMed ID: 30318451
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oncological and Survival Outcomes in Watch and Wait Patients With a Clinical Complete Response After Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Systematic Review and Pooled Analysis.
    Dattani M; Heald RJ; Goussous G; Broadhurst J; São Julião GP; Habr-Gama A; Perez RO; Moran BJ
    Ann Surg; 2018 Dec; 268(6):955-967. PubMed ID: 29746338
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term imaging characteristics of clinical complete responders during watch-and-wait for rectal cancer-an evaluation of over 1500 MRIs.
    Lambregts DMJ; Maas M; Boellaard TN; Delli Pizzi A; van der Sande ME; Hupkens BJP; Lahaye MJ; Bakers FCH; Beets GL; Beets-Tan RGH
    Eur Radiol; 2020 Jan; 30(1):272-280. PubMed ID: 31428827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rectal cancer: Watch-and-wait and continuing the rectal-preserving strategy with local excision for incomplete response or limited regrowth.
    Al-Najami I; Jones HJ; Dickson EA; Muirhead R; Deding U; James DR; Cunningham C
    Surg Oncol; 2021 Jun; 37():101574. PubMed ID: 33853031
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rectal Sparing Approach After Neoadjuvant Therapy in Patients with Rectal Cancer: The Preliminary Results of the ReSARCh Trial.
    Marchegiani F; Palatucci V; Capelli G; Guerrieri M; Belluco C; Rega D; Morpurgo E; Coco C; Restivo A; De Franciscis S; Aschele C; Perin A; Bonomo M; Muratore A; Spinelli A; Ramuscello S; Bergamo F; Montesi G; Spolverato G; Del Bianco P; Gambacorta MA; Delrio P; Pucciarelli S
    Ann Surg Oncol; 2022 Mar; 29(3):1880-1889. PubMed ID: 34855063
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 53. [Current status and perspectives on "watch and wait" strategy for rectal cancer patients after clinical complete response following neoadjuvant chemoradiation].
    Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):521-526. PubMed ID: 31238632
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Wait-and-see or radical surgery for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy: a cohort study.
    Li J; Liu H; Yin J; Liu S; Hu J; Du F; Yuan J; Lv B; Fan J; Leng S; Zhang X
    Oncotarget; 2015 Dec; 6(39):42354-61. PubMed ID: 26472284
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Initial magnetic resonance imaging tumour regression grade (mrTRG) as response evaluation after neoadjuvant treatment predicts sustained complete response in patients with rectal cancer.
    Suzuki C; Halperin SK; Nilsson PJ; Martling A; Holm T
    Eur J Surg Oncol; 2022 Jul; 48(7):1643-1649. PubMed ID: 35272899
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Watch-and-wait strategy in rectal cancer: Is there a tumour size limit? Results from two pooled prospective studies.
    Jankowski M; Pietrzak L; Rupiński M; Michalski W; Hołdakowska A; Paciorek K; Rutkowski A; Olesiński T; Cencelewicz A; Szczepkowski M; Zegarski W; Reszke J; Richter P; Wawok P; Małecki K; Bębenek M; Szelachowska J; Mazurek M; Gisterek I; Polkowski W; Jankiewicz M; Styliński R; Socha J; Bujko K;
    Radiother Oncol; 2021 Jul; 160():229-235. PubMed ID: 34023328
    [TBL] [Abstract][Full Text] [Related]  

  • 57. "WATCH AND WAIT" STRATEGY IN RECTAL CANCER PATIENTS WITH A COMPLETE CLINICAL RESPONSE AFTER NEOADJUVANT CHEMORADIATION THERAPY: A SINGLE-CENTER EXPERIENCE.
    Kokaine L; Radzina M; Liepa M; Gerina-Berzina A; Sīviņa E; Nikolajeva J; Gardovskis A; Gardovskis J; Miklaševičs E
    Exp Oncol; 2024 May; 46(1):53-60. PubMed ID: 38852052
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution.
    Perez RO; Habr-Gama A; Lynn PB; São Julião GP; Bianchi R; Proscurshim I; Gama-Rodrigues J
    Dis Colon Rectum; 2013 Jan; 56(1):6-13. PubMed ID: 23222274
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Response assessment after (chemo)radiotherapy for rectal cancer: Why are we missing complete responses with MRI and endoscopy?
    van der Sande ME; Beets GL; Hupkens BJ; Breukink SO; Melenhorst J; Bakers FC; Lambregts DM; Grabsch HI; Beets-Tan RG; Maas M
    Eur J Surg Oncol; 2019 Jun; 45(6):1011-1017. PubMed ID: 30528891
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
    Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
    Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.